Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Poster Session 1 - Cancer Biology

    • Type: Poster Session
    • Track: Biology
    • Presentations: 27
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.01-014 - Effects of combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor and the histone deacetylase inhibitor on NSCLC cells.

      12:32 - 12:46  |  Author(s): T. Takashina

      • Abstract

      Loading...

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-010 - Expression of α1,6-fucosyltransferase is associated with prognosis and histology in non-small cell lung cancers

      09:30 - 09:30  |  Author(s): R. Honma

      • Abstract

      Loading...

  • +

    P1.07 - Poster Session 1 - Surgery

    • Type: Poster Session
    • Track: Surgery
    • Presentations: 48
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.07-009 - Preoperative simulation and navigation using the combination of high-speed 3D-image analysis system and Robotic surgery increase the efficacy and accuracy in thoracic surgery

      09:30 - 09:30  |  Author(s): N. Kajiwara

      • Abstract

      Loading...

    • +

      P1.07-037 - Clinical characteristics of completely resected lung cancer with combined pulmonary fibrosis and emphysema

      09:30 - 09:30  |  Author(s): J. Osawa

      • Abstract

      Loading...

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-038 - The significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK target therapy

      09:30 - 09:30  |  Author(s): N. Zhang

      • Abstract

      Loading...

  • +

    P1.15 - Poster Session 1 - Thymoma

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 9
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.15-004 - Relationship of therapeutic results with immunohistochemical findings in thymic carcinoma cases

      09:30 - 09:30  |  Author(s): T. Kimura

      • Abstract

      Loading...

  • +

    P1.22 - Poster Session 1 - Epidemiology, Etiology

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 12
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.22-005 - A Prospective, Molecular Epidemiological Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer with Adenocarcinoma Histology (PIONEER study) - China Subset Analysis

      09:30 - 09:30  |  Author(s): Y. Shi

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.02 - MicroRNA Signature Predicts Survival in Resectable Small-Cell Lung Cancer

      10:40 - 10:50  |  Author(s): N. Bi

      • Abstract

      Loading...

  • +

    O07 - Supportive and Surgical Care

    • Type: Oral Abstract Session
    • Track: Surgery
    • Presentations: 8
    • Moderators:M. Culligan
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Gallery A, Level 1
    • +

      O07.01 - Randomized phase III trial of aprepitant compared with dexamethasone for emesis induced by carboplatin

      10:30 - 10:40  |  Author(s): K. Takeda

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO08 - NSCLC - Early Stage

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:K. Nakagawa
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Gallery B, Level 1
    • +

      MO08.11 - The role of aggressive local therapy and prognostic factors in postoperative recurrent non-small cell lung cancer: Is oligorecurrence state potential curable disease?

      17:15 - 17:20  |  Author(s): Y. Shimada

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging

    • Type: Poster Session
    • Track: Biology
    • Presentations: 27
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.05-015 - A novel CRM1 inhibitor targeting for NSCLC with EGFR-TKI resistance mutation

      09:30 - 09:30  |  Author(s): S. Wang

      • Abstract

      Loading...

    • +

      P2.05-027 - Generation and Biological Character Analysis of EGFR-TKI Resistant Cell Line

      09:30 - 09:30  |  Author(s): Y. Shi

      • Abstract

      Loading...